StonvexLoading…
StonvexStonvexStonvexCore line items from REZI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.91B | $7.47B | $5.58B | $3.71B |
Operating Income | $102.00M | $607.00M | $467.00M | $313.00M |
Net Income | $38.00M | $-527.00M | $-663.00M | $-819.00M |
EPS (Diluted) | $0.17 | $-3.77 | $-4.62 | $-5.65 |
Total Assets | $8.21B | $8.43B | $8.19B | $8.52B |
Total Liabilities | $5.29B | $5.52B | $5.42B | $5.90B |
Cash & Equivalents | $438.00M | $661.00M | $345.00M | $753.00M |
Free Cash Flow OCF − CapEx | $-181.00M | $-1.25B | $-1.51B | $84.00M |
Shares Outstanding | 151.00M | 150.00M | 150.00M | 149.00M |